Cerebrovascular Specialty Partener
Boehringer Ingelheim
Total des années d'expérience :12 years, 2 Mois
- Central region from 04/2018
- Manage Governmental and private accounts putting sales and marketing plans for thrombolytic s
Actilyse and Matalyse
- Reported to the franchise head
- Marketing Responsibilities: Angels initiative
https://www.angels-initiative.com
A world wide initiative project for improving the number of patients treated in stroke ready hospitals by
putting protocols and activating stroke codes in new hospitals and to optimize the quality of treatment
in all existing stroke centers.
- Governmental Medical Representative
From 08/2016 till 12/2017 Responsible for CV portfolio
Pradaxa ( New oral Anticoagulant )
Micardis ( anti-hypertensive )
In Ministry Of Health hospitals and related medical supplies and armed Force hospitals
Closing the year with 167% achievement and best practice recognition and reward.
From 1st of Jan 2018 i responsible for all sector in my area MOH, institutions and Private business
continue working on : Pradaxa, Micardis and Twynesta as BI CV portfolio
Cardio metabolic franchise
Responsible for Exforge range (Exforge and Exforge HCT) anti hypertensive drugs.
T2 2014 Exforge Best achiever and recognition award for doubling Exforge market share.
2015 top 5 Best Achievers
Team SFE (CRM) champion
Work with Orthopedics, Surgeons and Internal medicine specialties
Launch “IBSA-Switzerland” products:
Intragel (Hyaluronic acid intraarticular injection)
Dexaglobe Amp. (Corticosteroid injection)
Ialugen Plus (Hyaluronic acid for Treatment of infected wounds and burns)
Also responsible for Flector caps, Harpagin Tabs and Thiotex Caps